IFNG and neoplasm: FUS1/TUSC2-induced decrease of PD-L1 expression in response to its main inducer, IFN gamma, modifies tumor microenvironment, unleashes T and NK cells from inhibition, and allows effective use of PD-1 blockers [24, 140].